CTIVX | PONCX | CTIVX / PONCX | |
Total Expense Ratio | 0.65 | 1.69 | 38% |
Annual Report Gross Expense Ratio | 0.65 | 1.69 | 38% |
Fund Existence | 15 years | 18 years | - |
Gain YTD | 6.810 | 7.148 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.98B | 198B | 3% |
Annual Yield % from dividends | 5.30 | 4.95 | 107% |
Returns for 1 year | 5.02 | 5.85 | 86% |
Returns for 3 years | 22.40 | 21.50 | 104% |
Returns for 5 years | 15.13 | 15.96 | 95% |
Returns for 10 years | 45.77 | 43.37 | 106% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TUGN | 26.23 | 0.15 | +0.59% |
STF Tactical Growth & Income ETF | |||
VTN | 10.85 | 0.01 | +0.09% |
Invesco Trust for Investment Grade New York Municipals | |||
IBRN | 25.42 | N/A | N/A |
iShares Neuroscience and Healthcare ETF | |||
EAGL | 31.08 | -0.21 | -0.67% |
Eagle Capital Select Equity ETF | |||
ATMP | 28.37 | -0.48 | -1.65% |
Barclays ETN+ Select MLP |